Eye Health News and Research

Latest Eye Health News and Research

Choosing better sunglasses to protect kids' eyes from damaging rays

Summer months are just on the horizon bringing wonderful warm days filled with sunshine. For most parents, sending kids outside to play includes lathering them with sunscreen to protect their skin from too much of the sun's UVA and UVB rays, but what about protecting their children's eyes?

31 May 2013

Taking precautions to protect health during summer

Summer is a time for enjoying warm weather, but spending time outside also increases the risk of contracting serious conditions like Lyme disease, poison ivy rashes, West Nile virus and allergic reactions to bee stings.

31 May 2013

$Study provides insights into characteristics of sports-related facial fractures in young athletes$

Study provides insights into characteristics of sports-related facial fractures in young athletes

Facial fractures are relatively common, and potentially serious, sports-related injuries among children participating in a wide range of sports, according to a study in the June issue of Plastic and Reconstructive Surgery-, the official medical journal of the American Society of Plastic Surgeons.

30 May 2013

Strengthening miniaturized titanium-based medical devices: an interview with Dr Masaru Rao, University of California, Riverside

While titanium is used widely for more conventional macro-scale medical devices (e.g. hip implants, dental implants, and cardiac pacemakers), its use for micro- and nano-scale devices has been limited thus far.

29 May 2013

EMA grants Sucampo orphan drug designation for unoprostone isopropyl to treat retinitis pigmentosa

Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, today announced that it has received orphan drug designation in the European Union for unoprostone isopropyl for the treatment of retinitis pigmentosa (RP). RP is a genetic disease characterized by progressive, irreversible vision loss and decreasing visual acuity, and there are no drugs or therapeutic procedures currently approved for the treatment of RP today.

29 May 2013

Medicare paying for an increasing number of 'functional' eye lifts

The public health insurance program for people over 65 typically does not cover cosmetic surgery, but for cases in which a patient's sagging eyelids significantly hinder their vision, it does pay to have them lifted.

29 May 2013

Crittenton researchers receive grant to study trauma treatment in children

Crittenton Children's Center has received a two-year, $10,000 grant from the Eye Movement Desensitization and Reprocessing Research Foundation to conduct a first of its kind study addressing trauma in children.

29 May 2013

Perceptual learning may hold promise for improving visual functions in people with central vision loss

Perceptual learning techniques may provide a useful new approach to rehabilitation in patients with central vision loss-taking advantage of visual plasticity that persists even in old age, according to a special article in the June issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

28 May 2013

Alcon launches JETREA in Denmark and Sweden

ThromboGenics NV, an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, today announces that its partner Alcon has launched JETREA in Denmark and Sweden, the third and fourth European markets where the product is now available.

28 May 2013

TF-CBT and EMDR are effective treatments for posttraumatic stress disorder

Trauma-focused cognitive-behavioral therapy (TF-CBT) and eye movement desensitization and reprocessing (EMDR) are effective treatments for posttraumatic stress disorder.

27 May 2013

NTU's new medical school to use plastinated human bodies for medical education

Nanyang Technological University's new medical school will be pioneering the use of plastinated bodies for medical education in Singapore.

27 May 2013

Children with Type 2 diabetes are at high risk to develop heart, kidney and eye problems

The news about youth and diabetes keeps getting worse. The latest data from the national TODAY diabetes study shows that children who develop Type 2 diabetes are at high risk to develop heart, kidney and eye problems faster and at a higher rate than people who acquire Type 2 diabetes as adults.

26 May 2013

Highlights: Geography's role in elective surgeries in Calif.; Conn. Democrats eye shifting $400M in Medicaid money; HHS says Cedars-Sinai has $2.2M in billing errors

Geography plays a role in whether patients in California have elective operations such as joint replacement, weight loss surgery and gallbladder removal, according to a new study. The California HealthCare Foundation study showed wide variations in patient surgeries across the state (Gorman, 5/22).

24 May 2013

Merck updates on preladenant clinical program for treatment of Parkinson's disease

Merck, known as MSD outside the United States and Canada, today provided an update on the clinical program for preladenant, Merck's investigational adenosine A2A receptor antagonist for the treatment of Parkinson's disease.

24 May 2013

Immune system attacks beneficial bacteria in several chronic human diseases

The human gut is loaded with commensal bacteria - "good" microbes that, among other functions, help the body digest food. The gastrointestinal tract contains literally trillions of such cells, and yet the immune system seemingly turns a blind eye. However, in several chronic human diseases such as inflammatory bowel disease, HIV/AIDS, cancer, cardiovascular disease, and diabetes, the immune system attacks these normally beneficial bacteria, resulting in chronic inflammation and contributing to disease progression.

23 May 2013

Merck releases statement on FDA's Advisory Committee meeting about suvorexant

Merck, known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of the U.S. Food and Drug Administration about suvorexant, Merck's investigational medicine to treat insomnia.

23 May 2013

Cognoptix' SAPPHIRE II eye test identifies Alzheimer's disease patients via Ab signature in the eyes

Cognoptix, an emerging medical device company, announced today that its SAPPHIRE II eye test identified Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes in a 10-subject proof-of-concept clinical trial.

23 May 2013

Study provides comprehensive blueprint for understanding diabetes

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

22 May 2013

Prostaglandin analogues cause droopy eyelids, new study finds

Prostaglandin analogues, drugs which lower intraocular pressure, are often the first line of treatment for people with glaucoma, but their use is not without risks.

22 May 2013

IRS scandal, HHS fundraising stir the health law political pot

The Obama administration's efforts to raise money from private sources for the health law have led some likely donors to become "skittish." Meanwhile, as GOP lawmakers seek to link the Internal Revenue Service issues to the health law, media outlets examine the IRS's reach in this regard.

21 May 2013

Eye Health News and Research

Latest Eye Health News and Research

Choosing better sunglasses to protect kids' eyes from damaging rays

Taking precautions to protect health during summer

Study provides insights into characteristics of sports-related facial fractures in young athletes

Strengthening miniaturized titanium-based medical devices: an interview with Dr Masaru Rao, University of California, Riverside

EMA grants Sucampo orphan drug designation for unoprostone isopropyl to treat retinitis pigmentosa

Medicare paying for an increasing number of 'functional' eye lifts

Crittenton researchers receive grant to study trauma treatment in children

Perceptual learning may hold promise for improving visual functions in people with central vision loss

Alcon launches JETREA in Denmark and Sweden

TF-CBT and EMDR are effective treatments for posttraumatic stress disorder

NTU's new medical school to use plastinated human bodies for medical education

Children with Type 2 diabetes are at high risk to develop heart, kidney and eye problems

Highlights: Geography's role in elective surgeries in Calif.; Conn. Democrats eye shifting $400M in Medicaid money; HHS says Cedars-Sinai has $2.2M in billing errors

Merck updates on preladenant clinical program for treatment of Parkinson's disease

Immune system attacks beneficial bacteria in several chronic human diseases

Merck releases statement on FDA's Advisory Committee meeting about suvorexant

Cognoptix' SAPPHIRE II eye test identifies Alzheimer's disease patients via Ab signature in the eyes

Study provides comprehensive blueprint for understanding diabetes

Prostaglandin analogues cause droopy eyelids, new study finds

IRS scandal, HHS fundraising stir the health law political pot

Genetics & Genomics - Second Edition eBook

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Newsletters you may be interested in